v3.25.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 61,026 $ 55,454
Marketable securities 159,561 188,293
Prepaid expenses and other current assets 4,829 5,854
Total current assets 225,416 249,601
Property and equipment, net 10,351 9,964
Restricted cash 1,708 1,708
Other assets 24 68
Operating lease right-of-use assets 21,192 22,641
Total assets 258,691 283,982
Current liabilities:    
Accounts payable 4,069 3,785
Accrued expenses and other current liabilities 6,454 8,531
Operating lease liabilities 9,114 9,067
Deferred revenue 51,672 45,606
Total current liabilities 71,309 66,989
Operating lease liabilities, net of current portion 25,738 28,064
Deferred revenue, net of current portion 222,440 234,457
Other liabilities 856 0
Total liabilities 320,343 329,510
Commitments and contingencies (Note 9)
Stockholders’ deficit:    
Preferred stock, $0.0001 par value; 25,000,000 shares authorized at March 31, 2025 and December 31, 2024; no shares issued and outstanding at March 31, 2025 and December 31, 2024 0 0
Common stock, $0.0001 par value; 175,000,000 shares authorized at March 31, 2025 and December 31, 2024; 55,721,340 shares issued and outstanding at March 31, 2025 and 55,594,131 shares issued and outstanding at December 31, 2024 6 6
Additional paid-in capital 515,346 512,515
Accumulated other comprehensive gain 14 135
Accumulated deficit (577,018) (558,184)
Total stockholders’ deficit (61,652) (45,528)
Total liabilities and stockholders’ deficit $ 258,691 $ 283,982